Atlas · Release history
Atlas release history
Current release is 0.4.0. Each release below records what Atlas does, and the limits that apply to it, at the point it shipped.
Atlas now reads company SEC filings for program names. A dataset set up by drug target can add the programs that filings tie to that target, and an intervention name can show other names a filing gives the same program.
- When chat's criteria name a drug target PhaseFolio has reviewed, such as TL1A, Atlas adds the program names that company SEC filings tie to that target. They arrive after chat answers, as one listed change you can undo, and chat never reads the filings.
- Opening an intervention name shows other names a company's SEC filing gives for the same program, with the sentence that states both and how many filings do. CSV and Excel exports list them in their own Also reported as table.
- Each name from a filing shows the company, the form, the filing date, one sentence quoted exactly as filed and a link to the filing on sec.gov. The sources page sets out how each tie is read and reviewed.
Boundaries of this release
- Atlas reports what sources say. It does not give treatment advice, benefit-risk conclusions, cross-study efficacy rankings, probability-of-success estimates or valuation verdicts.
- A name from a filing is what the company's filing stated on its filing date, not a fact PhaseFolio has verified. Only companies that file with the SEC are covered, so a target or program with no names listed may still have them elsewhere.
- Atlas does not merge names. Each name keeps its own studies, and no row or count combines them.
- Chat reads your request and the release's criteria, never study records or filings. Program names from filings change which studies a dataset includes only through a change you can see and undo.
Datasets can now leave Atlas and be shared. Export a saved dataset to CSV or Excel, share a read-only link to it, and move it onto newer registry data while keeping the earlier version.
- Export a saved dataset to CSV or Excel. Every value names the registry record it came from, and the file explains its columns, so you can take it into your own spreadsheet, memo or AI assistant and check what comes back.
- Share a read-only link to one saved revision of a dataset. Anyone with the link can view it without an account. You can copy the link again or revoke it, and a revoked or unknown link opens a page saying it is not available.
- Shared and example pages load their studies into one table instead of page by page, and the export always has every study. Each value opens to its registry, record link, field and retrieval date.
- Shared and example pages say how many studies have registry records that state different values for phase, recruitment status, enrolment, start or primary completion. Compare records shows them side by side, each linked to its registry.
- From a shared or example page, a free account can export the dataset, make its own copy or ask its own question. If you sign up first, the action you chose finishes when you return.
- Three public example datasets, in oncology, immunology and rare disease.
- When newer registry data is published, a saved dataset offers Review newer data. Updating moves the dataset onto the newer data as a new revision, and the earlier revision stays.
- Each registry's study title appears in the table, the inspector and the study record. An EU Clinical Trials Register trial with a record for each country appears on one line.
- The side rail shows your plan and how many datasets and chat requests you have left. The new dataset page offers example requests, and Atlas shows each step it takes.
- Atlas no longer builds a dataset that matches no studies. It suggests changes to try instead.
- Shorter rows, columns that sort from the header, a timeline that scrolls sideways, and long criteria folded to a count. A value Atlas could not map gives its reason in plain words.
Boundaries of this release
- Atlas reports what sources say. It does not give treatment advice, benefit-risk conclusions, cross-study efficacy rankings, probability-of-success estimates or valuation verdicts.
- Where registry records disagree, Atlas shows each record's value. It does not reconcile them or decide which is right.
- A shared link shows the revision it was made from, as of that revision's data date. Anyone with the link can view it until it is revoked.
- A dataset holds at most 500 studies on every plan. Building one needs a condition or a drug, and a dataset's condition or drug can be widened only through chat.
Atlas leaves beta. Datasets are now built from a published PhaseFolio reference release that brings three registries together, set up in conversation, and kept as saved datasets on a free or paid plan.
- Datasets are built from a published, pinned PhaseFolio reference release that combines ClinicalTrials.gov, the EU Clinical Trials Information System (CTIS) and the EU Clinical Trials Register, rather than from a live registry search.
- Each registry record's statement is shown as that record gives it, linked to its record and field. A value Atlas could not map keeps its reason, and a field the release has not collected is labelled as not collected yet.
- Start a dataset by describing it. Atlas asks a question only when the answer changes which studies are included, lists each change it makes, and every change can be undone. You can choose the criteria yourself at any point.
- Save, reopen, undo and copy datasets. A saved dataset keeps its earlier revisions.
- Atlas Free includes three datasets. Atlas Pro, at US$100 a month, adds unlimited datasets.
Boundaries of this release
- Atlas reports what sources say. It does not give treatment advice, benefit-risk conclusions, cross-study efficacy rankings, probability-of-success estimates or valuation verdicts.
- Chat reads your request and the release's criteria, never study records. It does not summarize evidence or add studies on its own.
- A dataset reflects one reference release as of its data date. A field the release has not collected is labelled as such, not treated as absent from the registry.
Later notes
- October 10, 2026: Atlas Pro no longer has a listed price. It is set up after a conversation with us, by voucher or invoice. Atlas Free is unchanged.
- November 3, 2026: Atlas Pro is US$100 a month again, bought in Atlas through Stripe Checkout. Invoices are still set up after a conversation. Atlas Free is unchanged.
First recorded Atlas beta release. Atlas builds a source-linked comparator landscape around a stated question, keeping each record traceable to the registry entry it came from.
- Build a landscape from a comparison question, with the interpreted search scope shown and editable before any search runs.
- Select which retrieved records belong in the comparison, and inspect any field down to its exact value, registry field path and capture metadata.
- ClinicalTrials.gov is the activated source pack for comparator selection and evidence.
- Where enabled for an account, the CTIS companion beta displays European Medicines Agency public-portal records for viewing only. This preview is separate from activated comparison sources and does not support selection, evidence packets or model analysis.
- Fields a source does not report stay labelled as not reported, rather than blank or inferred.
- Saved landscapes keep the question, search scope, selected records and evidence as they stood. Refreshing creates a new revision and leaves the earlier one intact.
Boundaries of this release
- Atlas reports what sources say. It does not give treatment advice, benefit-risk conclusions, cross-study efficacy rankings, probability-of-success estimates or valuation verdicts.
- A bounded result is not a complete universe. A source that was not searched is recorded as not searched, which is different from a source that returned nothing.
- Source availability depends on your account and product lane. Creating an account does not by itself grant access to a source.